Cabotegravir for preventing HIV-1 in adults and young people (TA1106)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 5 November 2025
Lenacapavir for preventing HIV-1 in people aged 16 years or older [ID6495]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Bictegravir-Lenacapavir for HIV-1 infection [TSID12343]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC